specialist biomedical scientist cellular pathology phospho-histone h3 staining of uveal and...

45
Specialist Biomedical Scientist Cellular Pathology Phospho-histone H3 staining of uveal and choroidal melanomas

Upload: devin-trench

Post on 01-Apr-2015

217 views

Category:

Documents


2 download

TRANSCRIPT

Page 1: Specialist Biomedical Scientist Cellular Pathology Phospho-histone H3 staining of uveal and choroidal melanomas

Specialist Biomedical ScientistCellular Pathology

Phospho-histone H3 staining of uveal and choroidal melanomas

Page 2: Specialist Biomedical Scientist Cellular Pathology Phospho-histone H3 staining of uveal and choroidal melanomas

Anatomy of the eyeAnatomy of the eye

Page 3: Specialist Biomedical Scientist Cellular Pathology Phospho-histone H3 staining of uveal and choroidal melanomas

As normal as it gets

Iris Ciliary Body

Choroid

Page 4: Specialist Biomedical Scientist Cellular Pathology Phospho-histone H3 staining of uveal and choroidal melanomas

Anatomy of the eyeAnatomy of the eye

Page 5: Specialist Biomedical Scientist Cellular Pathology Phospho-histone H3 staining of uveal and choroidal melanomas
Page 6: Specialist Biomedical Scientist Cellular Pathology Phospho-histone H3 staining of uveal and choroidal melanomas

Risk FactorsRisk FactorsSimilar risk factors for cutaneous

melanomasIncidence of uveal melanomas is highest

in the white population with between 4 to 10 cases per million

UV light may be a risk factorCongenital ocular melanocytosisFamilial atypical mole and melanoma

syndrome (FAMM)

Page 7: Specialist Biomedical Scientist Cellular Pathology Phospho-histone H3 staining of uveal and choroidal melanomas

Prognostic Factors: ClinicalPrognostic Factors: ClinicalAge and Sex

Rare in childhoodRisk increases with age: most melanomas occur in patients

of late middle ageSlight male predominance, but this is not statistically

significantly linked to survivalTumour location

Location of the anterior margin of the tumour is an important predictor of prognosis and survival

Ciliary body tumours carry worst prognosisIris tumours have lowest mortality rateTumours adjacent to the optic disc have worse prognosis

Tumour sizeLarger tumour size indicates worse prognosisSmaller tumours capable of causing death through

metastasis

Page 8: Specialist Biomedical Scientist Cellular Pathology Phospho-histone H3 staining of uveal and choroidal melanomas

Prognostic: Cytogenetic and MolecularPrognostic: Cytogenetic and MolecularChromosome aberrations:

Monosomy 3 is predictor of poor prognosisAmplification of 8q is associated with reduced survivalLoss of 1p is associated with increase in mortality from

metastasesGain of 6p is associated with good prognosis

• Loss of tumour suppressor genes• P53

• Rb

• Mutations in tumour promoter genes correlate with prognosis• Poor prognosis:

• DDEF1

• NBS1

• Better prognosis

• C-myc

Page 9: Specialist Biomedical Scientist Cellular Pathology Phospho-histone H3 staining of uveal and choroidal melanomas

Prognostic Factors: HistopathologicalPrognostic Factors: Histopathological• Cell type

• Consistent prognostic factor• Spindle cell; epithelioid cell; mixed cell

• Spindle = best prognosis• Epithelioid = worst prognosis

• Microvascular patterns and microvascular density (MVD)

• Microvascular patterns: loops found in 60% of melanomas and associated with poorer prognosis

• High MVD = associated with shortened survival• Cell matrix interactions

• Expression of MMP-2 decreases survival• EGFR and IGF-1R linked with metastases

• Number of mitotic figures• Correlates with mortality

Page 10: Specialist Biomedical Scientist Cellular Pathology Phospho-histone H3 staining of uveal and choroidal melanomas

PHH3 is a Mitosis-specific MarkerPHH3 is a Mitosis-specific Marker• Core protein Histone H3

• Involved in maintaining the integrity of the DNA double helix within senescent cells

• Is phosphorylated at the serine 10 residue during mitosis

• Phosphorylation only occurs during mitosis and not during apoptosis

• Antibody which detects this phosphorylation event has been developed and used to detect mitotic figures in various different tumours

• Astrocytomas• Meningiomas• Uveal and choroidal melanomas

Page 11: Specialist Biomedical Scientist Cellular Pathology Phospho-histone H3 staining of uveal and choroidal melanomas

AimsAims• To perform immunohistochemical (IHC)

staining for phospho-histone H3 (PHH3) in choroidal melanoma

• To compare staining of mitotic figures using H & E staining and IHC staining with the PHH3 antibody

• To see if IHC staining correlates with clinical outcome, histopathological features and presence or absence of monosomy 3.

Page 12: Specialist Biomedical Scientist Cellular Pathology Phospho-histone H3 staining of uveal and choroidal melanomas

Materials and Methods: PopulationMaterials and Methods: Population• Previously diagnosed uveal melanomas

(1973 – 1992)• 60 enucleations• 50 local resections• 1 exenteration

• Groups• 1 = Metastasising• 2 = Non-metastasising

• Tissues fixed in glutaraldehyde or formalin and embedded in paraffin wax

Page 13: Specialist Biomedical Scientist Cellular Pathology Phospho-histone H3 staining of uveal and choroidal melanomas

Materials and Methods: H&E StainingMaterials and Methods: H&E Staining• Sections cut at 3µm• Harris’ haematoxylin• Alcoholic eosin• Automated staining

Page 14: Specialist Biomedical Scientist Cellular Pathology Phospho-histone H3 staining of uveal and choroidal melanomas

Materials and Methods: IHC StainingMaterials and Methods: IHC Staining• Bond™Max Automated

Immunohistochemistry Vision Biosystem• IHC Protocol J

• Bond dewax solution• Epitope Retrieval solution 2• Primary antibody: PHH3• Post primary alkaline phosphatase: rabbit

anti-mouse IgG• Polymer alkaline phosphatase: anti-rabbit

IgG• Fast red chromogen

• Haematoxylin counterstain

Page 15: Specialist Biomedical Scientist Cellular Pathology Phospho-histone H3 staining of uveal and choroidal melanomas

Materials and Methods: Counting MitosesMaterials and Methods: Counting Mitoses

• 30 high power fields (x40 lens)• Corresponds to an area of 10mm2

• Numbers obtained from H & E staining and PHH3 staining were compared

• Counting carried out by Ophthalmic Histopathologist

Page 16: Specialist Biomedical Scientist Cellular Pathology Phospho-histone H3 staining of uveal and choroidal melanomas

Materials and Methods: Statistical AnalysesMaterials and Methods: Statistical Analyses

• Two staining techniques compared using Wilcoxon Signed Rank Test

• Level of significance set at p < 0.05• Survival time for patients with metastasising

melanomas compared using Wilcoxon Rank Sum Test and the Kaplan- Meier non-parametric distribution analysis

• Level of significance set at p < 0.05• Correlations between the number of mitotic

figures (using PHH3) and histological parameters examined using the Kruskall-Wallis non-parametric test

• All completed using Minitab software

Page 17: Specialist Biomedical Scientist Cellular Pathology Phospho-histone H3 staining of uveal and choroidal melanomas

Results: Results: • 40 cases of metastasising melanomas

• Mean age 56.2 years (range 16.92 – 79.62)• 20 cases of non-metastasising

melanomas• Mean age of 52.8 (range 18 – 78)

• Ages of patients were statistically similar

• Male to female distribution was similar

• No significant differences in treatments

Page 18: Specialist Biomedical Scientist Cellular Pathology Phospho-histone H3 staining of uveal and choroidal melanomas

Results: Clinical and Histological Results: Clinical and Histological Parameters Parameters

Page 19: Specialist Biomedical Scientist Cellular Pathology Phospho-histone H3 staining of uveal and choroidal melanomas

Results: Clinical and Histological Results: Clinical and Histological Parameters Parameters

Page 20: Specialist Biomedical Scientist Cellular Pathology Phospho-histone H3 staining of uveal and choroidal melanomas
Page 21: Specialist Biomedical Scientist Cellular Pathology Phospho-histone H3 staining of uveal and choroidal melanomas
Page 22: Specialist Biomedical Scientist Cellular Pathology Phospho-histone H3 staining of uveal and choroidal melanomas
Page 23: Specialist Biomedical Scientist Cellular Pathology Phospho-histone H3 staining of uveal and choroidal melanomas
Page 24: Specialist Biomedical Scientist Cellular Pathology Phospho-histone H3 staining of uveal and choroidal melanomas
Page 25: Specialist Biomedical Scientist Cellular Pathology Phospho-histone H3 staining of uveal and choroidal melanomas
Page 26: Specialist Biomedical Scientist Cellular Pathology Phospho-histone H3 staining of uveal and choroidal melanomas
Page 27: Specialist Biomedical Scientist Cellular Pathology Phospho-histone H3 staining of uveal and choroidal melanomas
Page 28: Specialist Biomedical Scientist Cellular Pathology Phospho-histone H3 staining of uveal and choroidal melanomas

Still alive 20 years later Died 18 months after enucleation

Page 29: Specialist Biomedical Scientist Cellular Pathology Phospho-histone H3 staining of uveal and choroidal melanomas

Results: Mitotic Figure StainingResults: Mitotic Figure Staining

Page 30: Specialist Biomedical Scientist Cellular Pathology Phospho-histone H3 staining of uveal and choroidal melanomas

Results: Mitotic Figure StainingResults: Mitotic Figure Staining

Page 31: Specialist Biomedical Scientist Cellular Pathology Phospho-histone H3 staining of uveal and choroidal melanomas

Results: Mitotic Figure StainingResults: Mitotic Figure Staining

Page 32: Specialist Biomedical Scientist Cellular Pathology Phospho-histone H3 staining of uveal and choroidal melanomas

Results: Mitotic Figure StainingResults: Mitotic Figure Staining

Page 33: Specialist Biomedical Scientist Cellular Pathology Phospho-histone H3 staining of uveal and choroidal melanomas

Results: Assessment of Mitotic RateResults: Assessment of Mitotic Rate

Comparison of staining with H&E and PHH3Non-metastasising melanoma : p = 0.009Metastasising melanoma: p < 0.0001All samples: p < 0.0001

Page 34: Specialist Biomedical Scientist Cellular Pathology Phospho-histone H3 staining of uveal and choroidal melanomas

Results: Prediction of Survival TimeResults: Prediction of Survival Time

Statistically significant differences between the two staining methods: therefore for subsequent analyses, data obtained from PHH3 were used

Page 35: Specialist Biomedical Scientist Cellular Pathology Phospho-histone H3 staining of uveal and choroidal melanomas

Number of mitotic figures were grouped:< 55 – 10> 10Groupings of mitotic figure counts were

compared using non-parametric tests:Wilcoxon Rank Sum TestKaplan-Meier

No statistically significant differences between survival times of patients in each grouping (p = 0.116)

Results: Survival TimeResults: Survival Time

Page 36: Specialist Biomedical Scientist Cellular Pathology Phospho-histone H3 staining of uveal and choroidal melanomas

Results: Kaplan-MeierResults: Kaplan-Meier

14121086420

100

80

60

40

20

0

Survival Time (years)

Perc

ent

<5>105-10

Mitoses

Indication that patients with >10 mitoses survive for a shorter length of time

Page 37: Specialist Biomedical Scientist Cellular Pathology Phospho-histone H3 staining of uveal and choroidal melanomas

Prediction of Mitoses from Histological Prediction of Mitoses from Histological FeaturesFeatures

Kruskal-Wallis non-parametric test determined correlations between mitoses and other featuresBalloon cells (p = 0.036)Pigment (p = 0.584)Number of lymphocytes (p = 0.268)Cell type (p = 0.986)Presence of vascular loops (p = 0.534)Necrosis (p = 0.832)Invasion of tumour into surrounding tissue (p =

0.820)Largest tumour dimension (p = 0.159)Survival time (p = 0.187)Monosomy 3 (p = 0.199)

Page 38: Specialist Biomedical Scientist Cellular Pathology Phospho-histone H3 staining of uveal and choroidal melanomas

DiscussionDiscussionPHH3 staining is a valid technique for

demonstrating mitotic figuresThe number of mitotic cells in some tumour

types is a good indicator of metastatic potential

Page 39: Specialist Biomedical Scientist Cellular Pathology Phospho-histone H3 staining of uveal and choroidal melanomas

DiscussionDiscussionUsing this technique:

Mitotic counts were elevated in 17 out of 40 (42.5%) cases of metastasising uveal melanomas when compared with H&E staining

Mitotic counts were elevated in 10 out of 20 (50%) of non-metastasising uveal melanomas when compared with H&E staining

Significant differences in the number of mitotic figures when stained with PHH3 and H&E

Non-metastasising melanomas: p = 0.0009Metastasising melanomas: p < 0.0001

Most likely reason: there are significantly more mitoses in metastasising melanoma than in non-metastasising melanoma

Page 40: Specialist Biomedical Scientist Cellular Pathology Phospho-histone H3 staining of uveal and choroidal melanomas

25 cases failed to stain with PHH3Historic tissues were used (some up to 39 years

old)Tissues lose antigenicity over time with long term

storageDiaminobenzidine (DAB) chromogen staining

is masked by the melanin pigment in the tumour

Double-staining will overcome this, but it is time-consuming

In this project, the red chromogen was used to distinguish between melanin pigment and mitotic figure staining

DiscussionDiscussion

Page 41: Specialist Biomedical Scientist Cellular Pathology Phospho-histone H3 staining of uveal and choroidal melanomas

DiscussionDiscussionIHC staining:

Allows easier recognition of mitotic figures (when compared to H&E staining)

Reduces the time required for counting mitotic figures by as much as 50.4%

Is relatively cheap to carry out (although the costs of individual reagents is more expensive than H&E staining)

Is less labour intensive than H&E staining (automated staining)

Facilitates counting of mitotic figures by BMS staff, allowing the histopathologist to undertake other duties

Page 42: Specialist Biomedical Scientist Cellular Pathology Phospho-histone H3 staining of uveal and choroidal melanomas

DiscussionDiscussionCorrelation between number of mitoses and:

Presence of balloon cells (p=0.036)No correlation between number of mitoses and:Pigment (p = 0.584)Number of lymphocytes (p = 0.268)Cell type (p = 0.986)Presence of vascular loops (p = 0.534)Necrosis (p = 0.832)Invasion of tumour into surrounding tissues (p =

0.820)Survival times (p = 0.187)Presence or absence of monosomy 3 (p=0.199)

Page 43: Specialist Biomedical Scientist Cellular Pathology Phospho-histone H3 staining of uveal and choroidal melanomas

Future WorkFuture WorkUsing PHH3 antibody to demonstrate the

number of mitoses in other tumour typesGIST

Developing an international standardised method for counting mitoses may be useful in order to aid classification of tumours

Comparison of the times taken for Histopathologist and BMS to count mitotic figures

Page 44: Specialist Biomedical Scientist Cellular Pathology Phospho-histone H3 staining of uveal and choroidal melanomas
Page 45: Specialist Biomedical Scientist Cellular Pathology Phospho-histone H3 staining of uveal and choroidal melanomas

Questions?Questions?